Hem › Interstitiella lungsjukdomar › Kansas › Kansas City
Kliniska studier för Interstitiella lungsjukdomar i Kansas City, KS
13 studier för Interstitiella lungsjukdomar söker deltagare vid platser i och runt Kansas City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekryterarFas 3
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RekryterarFas 3
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekryterarFas 3
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RekryterarFas 2
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RekryterarFas 2
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekryterarObservationsstudie
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
RekryterarFas 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekryterarFas 2/3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RekryterarFas 2
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RekryterarFas 3
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
RekryterarObservationsstudie
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RekryterarFas 1Friska volontärer välkomna
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
RekryterarObservationsstudie
- University of Kansas, Kansas City
Interstitiella lungsjukdomar-studier i andra städer
- New York City, NY18 studier
- Philadelphia, PA16 studier
- Los Angeles, CA14 studier
- Charleston, SC13 studier
- Durham, NC13 studier
- Chicago, IL12 studier
- Houston, TX12 studier
- Aurora, CO11 studier
- Ann Arbor, MI11 studier
- Salt Lake City, UT9 studier
- Dallas, TX9 studier
- Boston, MA9 studier
Andra studier i Kansas City
- Hjärt-kärlsjukdom14 studier
- Hjärtsvikt13 studier
- Övervikt13 studier
- Cystisk fibros13 studier
- Bröstcancer12 studier
- Blåscancer12 studier
- Akut myeloid leukemi12 studier
- Prostatacancer12 studier
- Icke-småcellig lungcancer11 studier
- Lungcancer11 studier
- KOL9 studier
- Astma8 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.